ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 660 filers reported holding ASTRAZENECA PLC in Q2 2020. The put-call ratio across all filers is 0.39 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $10,654,049 | -24.3% | 157,325 | -20.0% | 0.01% | -22.2% |
Q2 2023 | $14,068,873 | -9.3% | 196,575 | -12.0% | 0.01% | -18.2% |
Q1 2023 | $15,507,929 | -25.8% | 223,425 | -27.5% | 0.01% | -21.4% |
Q4 2022 | $20,904,435 | -1.3% | 308,325 | -20.2% | 0.01% | -12.5% |
Q3 2022 | $21,188,000 | -36.2% | 386,365 | -23.1% | 0.02% | -30.4% |
Q2 2022 | $33,199,000 | -38.0% | 502,489 | -37.7% | 0.02% | -30.3% |
Q1 2022 | $53,525,000 | +12.3% | 806,826 | -1.4% | 0.03% | +10.0% |
Q4 2021 | $47,642,000 | -6.0% | 817,895 | -3.1% | 0.03% | -9.1% |
Q3 2021 | $50,683,000 | -3.2% | 843,865 | -3.5% | 0.03% | -2.9% |
Q2 2021 | $52,354,000 | +18.3% | 874,026 | -1.8% | 0.03% | +6.2% |
Q1 2021 | $44,265,000 | -73.3% | 890,276 | -73.1% | 0.03% | -75.6% |
Q4 2020 | $165,725,000 | -79.6% | 3,315,172 | -77.6% | 0.13% | -82.4% |
Q3 2020 | $812,210,000 | -18.2% | 14,821,346 | -21.1% | 0.74% | -18.6% |
Q2 2020 | $993,050,000 | -25.6% | 18,775,763 | -37.2% | 0.91% | -36.8% |
Q1 2020 | $1,334,576,000 | -30.4% | 29,883,038 | -22.3% | 1.44% | -1.6% |
Q4 2019 | $1,918,360,000 | -12.8% | 38,474,930 | -22.0% | 1.47% | -18.9% |
Q3 2019 | $2,199,491,000 | +8.0% | 49,349,140 | +0.0% | 1.81% | +9.9% |
Q2 2019 | $2,036,630,000 | +1.9% | 49,336,962 | -0.2% | 1.65% | +0.4% |
Q1 2019 | $1,997,816,000 | +6.2% | 49,414,201 | -0.2% | 1.64% | -4.8% |
Q4 2018 | $1,880,633,000 | -7.1% | 49,516,401 | -3.2% | 1.72% | +11.3% |
Q3 2018 | $2,023,622,000 | +9.2% | 51,140,309 | -3.1% | 1.55% | +4.6% |
Q2 2018 | $1,852,924,000 | -2.8% | 52,774,809 | -3.2% | 1.48% | -3.9% |
Q1 2018 | $1,906,920,000 | -2.8% | 54,530,179 | -3.5% | 1.54% | +1.3% |
Q4 2017 | $1,961,625,000 | +3.0% | 56,530,979 | +0.6% | 1.52% | -0.8% |
Q3 2017 | $1,904,062,000 | -1.4% | 56,200,178 | -0.8% | 1.53% | -6.0% |
Q2 2017 | $1,931,862,000 | +9.0% | 56,669,449 | -0.4% | 1.63% | +8.2% |
Q1 2017 | $1,772,068,000 | +30.7% | 56,906,499 | +14.7% | 1.51% | +25.1% |
Q4 2016 | $1,355,443,000 | -2.2% | 49,613,588 | +17.6% | 1.20% | -7.6% |
Q3 2016 | $1,386,363,000 | +41.2% | 42,189,973 | +29.7% | 1.30% | +34.3% |
Q2 2016 | $982,163,000 | +33.9% | 32,532,723 | +24.9% | 0.97% | +35.1% |
Q1 2016 | $733,558,000 | +83.5% | 26,049,650 | +121.2% | 0.72% | +83.2% |
Q4 2015 | $399,834,000 | – | 11,777,132 | – | 0.39% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Healthcare Value Capital, LLC | 75,000 | $3,351,000 | 5.64% |
Galibier Capital Management Ltd. | 276,112 | $12,331,000 | 5.37% |
Hansberger Growth Investors, LP | 72,860 | $3,254,000 | 4.39% |
Sivik Global Healthcare LLC | 75,000 | $10,145,000 | 4.00% |
Eversept Partners, LP | 352,551 | $15,744,928 | 3.91% |
Integral Health Asset Management, LLC | 190,000 | $8,485,000 | 3.74% |
Pictet North America Advisors SA | 231,691 | $20,731,000 | 3.54% |
SPHERA FUNDS MANAGEMENT LTD. | 570,000 | $25,456,000 | 3.18% |
ZWJ INVESTMENT COUNSEL INC | 720,181 | $32,163,000 | 2.87% |
CRAWFORD INVESTMENT COUNSEL INC | 1,906,718 | $85,154,000 | 2.86% |